Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-065993

Chief Executive Officer acquired 60,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lynch Casey Chief Executive Officer 2021-11-18 Option exercise +60,000 $0.46 $27,600 109,895 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lynch Casey Chief Executive Officer 2021-11-18 Option exercise · Stock Option (Right to Buy) −60,000 23,159 D: show line 2 in the form
Loading xslF345X03/doc4.xml…